Identifiable Intangible Assets and Goodwill - Indefinite-lived Intangible Assets Percentage of Total Intangibles (Details)	Sep. 27, 2015
Trade Names [Member] | Global Innovative Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	0.00%
Trade Names [Member] | Global Vaccines, Oncology and Consumer Healthcare [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	69.00%
Trade Names [Member] | Global Established Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	31.00%
In Process Research and Development [Member] | Global Innovative Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	2.00%
In Process Research and Development [Member] | Global Vaccines, Oncology and Consumer Healthcare [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	9.00%
In Process Research and Development [Member] | Global Established Pharmaceutical [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	86.00%
Research and Development Expense [Member] | Trade Names [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	0.00%
Research and Development Expense [Member] | In Process Research and Development [Member]
Indefinite-lived Intangible Assets [Line Items]
Percentage of total identifiable intangible assets, less accumulated amortization	3.00%